1 |
Pallisco R, Lazzarino G, Bilotta G, Marroni F, Mangione R, Saab MW, Brundo MV, Pittalà A, Caruso G, Capoccia E, Lazzarino G, Tavazzi B, Bilotta P, Amorini AM. Metabolic Signature of Energy Metabolism Alterations and Excess Nitric Oxide Production in Culture Media Correlate with Low Human Embryo Quality and Unsuccessful Pregnancy. Int J Mol Sci 2023;24. [PMID: 36614333 DOI: 10.3390/ijms24010890] [Reference Citation Analysis]
|
2 |
Logan A, Mazzon M, Bruce L, Barnes NM. A clinical stage LMW-DS drug inhibits cell infection by coronaviruses and modulates reactive cytokine release from microglia.. [DOI: 10.1101/2022.09.07.506919] [Reference Citation Analysis]
|
3 |
Logan A, Belli A, Di Pietro V, Tavazzi B, Lazzarino G, Mangione R, Lazzarino G, Morano I, Qureshi O, Bruce L, Barnes NM, Nagy Z. The mechanism of action of a novel neuroprotective low molecular weight dextran sulphate: New platform therapy for neurodegenerative diseases like Amyotrophic Lateral Sclerosis. Front Pharmacol 2022;13:983853. [DOI: 10.3389/fphar.2022.983853] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
4 |
Logan A, Nagy Z, Barnes NM, Belli A, Di Pietro V, Tavazzi B, Lazzarino G, Lazzarino G, Bruce L, Persson LI. A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral Sclerosis. PLoS One 2022;17:e0267183. [PMID: 35613082 DOI: 10.1371/journal.pone.0267183] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|